[1] KIM S, TURKER M S,CHI E Y,et al. Preparation of muhivesicular liposomes[J]. Biochim Biophys Acta,1983,728(3): 339-348. [2] ALLEN T M,HANSEN C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose[J]. Biochem Biophys Acta,1991,1068(2): 133-141. [3] MOURTAS S,DURAJ S,FOTOPOULOU S,et al. Integrity of liposomes in presence of various formulation excipients,when dispersed in aqueous media and in hydrogels[J]. Colloid Surface B,2008,61(2): 270-276. [4] BATZRI S,KORN E D. Single bilayer liposomes prepared without sonication[J]. Biochim Biophys Acta,1973,298(4): 1015-1019. [5] MAITANI Y,IGARASHI S,SATO M,et al. Cationic liposome(DC-Chol/DOPE=1:2)and a modified ethanol injection method to prepare liposomes,increased gene expression[J]. Inter J Pharm,2007,342(1-2): 33-39. [6] FAN M H,XU S Y,XIA S Q,et al. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study[J]. Eur Food Res Technol,2008,227(1): 167-174. [7] WAGNER A,VORAUER-UHL K,KREISMAYR G,et al. The crossflow injection technique: An improvement of the ethanol injection method[J]. J Liposome Res,2002,12(3): 259-270. [8] STACHOWIAK J C,RICHMOND D L,THOMAS H L,et al. Inkjet formation of unilamellar lipid vesicles for cell-like encapsulation[J]. Lab Chip,2009,9(14): 2003-2009. [9] SAKAI H,GOTOH T,IMURA T,et al. Preparation and properties of liposomes composed of various phospholipids with different hydrophobic chains using a supercritical reverse phase evaporation method[J]. J Oleo Sci,2008,57(11): 613-621. [10] GARGA M,GARG B R,JAINC S,et al. Radiolabeling,pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes[J]. Euro J Pharm Sci,2008,33(3): 271-281. [11] NAIK S,PATEL D,SURTI N,et al. Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology[J]. J Supercritical Fluids,2010,54(1): 110-119. [12] OTAKE K,SHIMOMURA T,GOTO T,et al. Preparation of liposomes using an improved supercritical reverse phase evaporation method[J]. Langmuir,2006,22(6): 2543-2550. [13] ZHIGALTSEV I V,MAURER N,AKHONG Q F,et al. Liposome-encapsulated vincristine,vinblastine and vinorelbine: A comparative study of drug loading and retention[J]. J Controlled Release,2005,104(1): 103-111. [14] YANG X J,ZHAO X B,PHELPS M A,et al. A novel liposomal formulation of flavopiridol[J]. Inter J Pharm,2009,365(1-2): 170-174. [15] QIU L Y,JING N,JIN Y. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method[J]. Inter J Pharm,2008,361(1-2): 56-63. [16] CHEMIN C,PAN J M,BOURGAUX C,et al. Supramolecular organization of S12363-liposomes prepared with two different remote loading processes[J]. Bioch Biophys Acta(BBA)-Biomembranes,2009,1788(5): 926-935. [17] PAN X Q,WANG H Q,SHUKLA S,et al. Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy[J]. Bioconjug Chem,2002,13(3): 435-442. [18] SONG C K,JUNG S H,KIM D D,et al. Disaccharide-modified liposomes and their in vitro intracellular uptake[J]. Inter J Pharm,2009,380(1-2): 161-169. [19] LI C L,CUI J X,WANG C X,et al. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone[J]. Inter J Pharm,2008,362(1-2): 60-66. [20] RISTORI S,SALVATI A,MARTINI G,et al. Synthesis and liposome insertion of a new poly(carboranylalkylthio)porphyrazine to improve potentiality in multiple-approach cancer therapy[J]. J Am Chem Soc,2007,129(10): 2728-2729. [21] LUNDQUIST A,WESSMAN P,RENNIE A R,et al. Melittin-lipid interaction: A comparative study using liposomes,micelles and bilayerdisks[J]. Biochim Biophys Acta(BBA)-Biomembranes,2008,1778(10): 2210-2216. [22] NGWENIFORM P,ABBINENI G,CAO B,et al. Self-assembly of drug-loaded liposomes on genetically engineered target-recognizing M13 phage: A novel nanocarrier for targeted drug delivery[J]. Small,2009,5(17): 1963-1969. [23] NIU S L,DOCTROW B,MITCHELL D C. Rhodopsin activity varies in proteoliposomes prepared by different techniques[J]. Biochemistry,2009,48(1): 156-163. [24] LEHTINEN L,HYVNEN Z,SUBRIZI A,et al. Glycosaminoglycan-resistant and pH-sensitive lipid-coated DNA complexes produced by detergent removal method[J]. J Controlled Release,2008,131(2): 145-149. [25] LI Z,YU L,ZHENG L Q,et al. Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method[J]. J Therm Anal,2010,99(2): 689-693. [26] CHRISTENSEN D, KIRBY D, FOGED D,et al. α,α′-Trehalose 6,6′-dibehenate in non-phospholipid- based liposomes enables direct interaction with trehalose,offering stability during freeze-drying[J]. Biochim Biophys Acta(BBA)-Biomembranes,2008,1778(5): 1365-1373. [27] WANG T,DENG Y,GENG T,et al. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions[J]. Biochiim Biophys Acta(BBA)-Biomembranes,2006,1758(2): 222-131. [28] MORTAZAVI S M,MOHAMMADABADI M R,KHOSRAVI-DARANI K,et al. Preparation of liposomal gene therapy vectors by a scalable method without using volatile solvents or detergents[J]. J Biotechnol,2007,129(4): 604-613. [29] MOZAFARI M R,REED C J,ROSTRON C. Cytotoxicity evaluation of anionic nanoliposomes and nano- lipoplexes prepared by the heating method without employing volatile solvents and detergents[J]. Die Pharmazie,2007,62(3): 205-209. [30] CASTOR P T. Phospholipid nanosomes[J]. Current Drug Delivery,2005,2(4): 329-340. [31] GAUR P K,MISHRA S,GUPTA V B,et al. Targeted drug delivery of Rifampicin to the lungs: formulation,characterization,and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome[J]. Drug Develop Ind Pharm,2010,36(6): 638-646. [32] KAJIWARA E,KAWANO K,HATTORI Y,et al. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy[J]. J Controlled Release,2007,120: 104-110. [33] ZHAO Y Z,LU C T. Increasing the entrapment of protein-loaded liposomes with a modified freeze- thaw technique: A preliminary experimental study[J]. Drug Develop Ind Pharm,2009,35(2): 165-171. [34] QIN J,CHEN D W,LU W G, et al. Preparation, characterization,and evaluation of liposomal ferulic acid in vitro and in vivo[J]. Drug Develop Ind Pharm,2008,34(6): 602-608. [35] LI N,ZHUANG C Y,WANG M,et al. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery[J]. Inter J Pharm,2009,379(1): 131-138. [36] KHEIROLOMOOM A,KRUSE D E,QIN S,et al. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system[J]. J Controlled Release,2010,141(2): 128-136. [37] CHANGSAN N,CHAN H K,SEPAROVIC F,et al. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation[J]. J Pharm Sci,2009, 98(2): 628-639. [38] YU J X,THOMAS J A. Synergistic effects of surfactants and sugars on lipoplex stability during freeze- drying and rehydration[J]. J Pharm Sci,2009,98(9): 3319-3328. [39] KAZUMIA O, KASAIAKI H, HAJIME K. Method of liposome production, China, CN00817307.9[P]. 2003-04-16. [40] CHOUGULE M,PADHI B,MISRA A. Development of spray dried liposomal dry powder inhaler of dapsone[J]. AAPS Pharm Sci Tech,2008,9(1): 47-53. [41] NIRALE N M,VIDHATE R D,NAGARSENKER M S. Fluticasone propionate liposomes for pulmonary delivery[J]. Ind J Pharm Sci,2009,71(6): 709-711. [42] SNCHEZ S,ABEL A,MARZOA J,et al. Characterisation and immune responses to meningococcal recombinant porin complexes incorporated into liposomes[J]. Vaccine,2009,27(39): 5338-5343. [43] LEE J M,CHO Y J,PARK D J,et al. Preparation of nano-liposome by sonication and pressure[J]. Korean J Food Sci Technol,2008,40(1): 115-117. [44] XIANG G Y,WU J,LU Y H,et al. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes[J]. Inter J Pharm,2008,356(1-2): 29-36. [45] RAMEZANI M,KHOSHHAMDAM M,DEHSHAHRI A,et al. The influence of size,lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes[J]. Coll Surfaces B: Bioniterfaces,2009,72(1): 1-5. [46] PEREIRA de SOUZA,STANO P,LUISI P L. The minimal size of liposome-based model cells brings about a remarkably enhanced entrapment and protein synthesis[J]. Chem Bio Chem,2009,10(6): 1056-1063. [47] PUPO E,PADRN A,SANTANA E,et al. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization-extrusion technique[J]. J Controlled Release,2005,104(2): 379-396. [48] TAKAHASHI M,UECHI S,TAKARA K,et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin[J]. J Agric Food Chem,2009,57(19): 9141-9146. [49] MUKHERJEE S,STONE W L,YANG H,et al. Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes[J]. J Biochem Mol Toxicol,2009,23(2): 143-153. [50] NONGONIERMA A B,ABRLOVA M,FENELON M A,et al. Evaluation of two food grade proliposomes to encapsulate an extract of a commercial enzyme preparation by microfluidization[J]. J Agric Food Chem,2009,58(7): 3291-3297. [51] WEI W,SHI S J,LIU J,et al. Lipid nanoparticles loaded with 10-hydroxycamptothecin- phospholipid complex developed for the treatment of hepatoma in clinical application[J]. J Drug Target,2010,18(7): 557-566. [52] LONGMUIR K J,HAYNES S M,BARATTA J L,et al. Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate[J]. Int J Pharm,2009,382(1-2): 222-233. [53] DA SILVA MALHEIROS P,MICHELETTO Y M S,DA SILVEIRA N P,et al. Development and characterization of phosphatidylcholine nanovesicles containing the antimicrobial peptide nisin[J]. Food Res Inter,2010,43(4): 1198-1230. [54] HAENSLER J. Liposomal adjuvants: Preparation and formulation with antigens[J]. Vaccine Adjuvants: Methods in Molecular Biology,2010,626: 73-90. [55] HUI P K, BISHOP J E, MADRIGAL J E S. Preparation of a lipid bleud and aphospholipid suspension containing the lipid bleud and contrast agents based on these european EP1419789[P]. 2009-11-11. [56] STENSRUD G,SANDE S A,KRISTENSEN S,et al. Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design[J]. Inter J Pharm,2000,198(2): 213-228. [57] LISOVSKAYA A G,SOSNOVSKAYA A A,SHADYRO O I,et al. γ- and UV-radiation-induced degradation of sphingomyelin,lysosphingomyelin,and related compounds[J]. High Energy Chem,2009,43(6): 440-444. [58] STENSRUD G,MNKKNEN J,KARLSEN J. Toxicity of gamma irradiated liposomes: 2. In vitro effects on cells in culture[J]. Inter J Pharm,1999,178(1): 47-53. [59] VAAGE J,MAYHEW E,LASIC D,et al. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes[J]. Inter J Cancer,2006,51(6): 942-948. [60] LU Y,LI J,WANG G. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid[J]. Inter J Pharm,2008,356(1-2): 274-281. [61] SIVAKUMAR P A,RAO K P. Development of stable polymerized vinyl pyrrolidone-cholesteryl methacrylate liposomes as carriers for drug delivery[J]. Biomed Microdevices,2002,4(3): 197-204. [62] SAKAGUCHI N,KOJIMA C,HARADA A,et al. Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: Their ability to sensitize stable liposomes to pH[J]. Bioconjug Chem,2008,19(5): 1040-1048. [63] SIMARD P,LEROUX J C. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells[J]. Inter J Pharm,2009,381(2): 86-96. [64] WENG K C,NOBLE C O,PAPAHADJOPOULOS-STERNBERG B. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo[J]. Nano Letters,2008,8(9): 2851-2857.